
- Dermatology Times, April 2023 (Vol. 44. No. 04)
- Volume 44
- Issue 04
Spring into Rejuvenated Goals in Your Practice
Now that we’re 4 months into 2023, many New Year’s resolutions have ended up in the rearview mirror. The great thing about goal setting is that there is not a right or wrong time to recharge your batteries and determine what you would like to accomplish in both your personal and professional life. The Dermatology Times® team has you covered, whether you are interested in integrating new technology into your treatment options, familiarizing yourself with rare skin conditions, or locking inyour practice’s legal and financial security.
In this month’s issue, learn about the latest technology available to treat port-wine stains, as well as the striking before and after results; take a look at the connection between lipid-lowering drugs and psoriasis management; and learn about the latest in rosacea treatment as we recognize Rosacea Awareness Month. On the medical practice side of things, you will discover how to master tax-favored assets with David B. Mandell, JD, MBA, and Carole C. Foos, CPA. They answer questions on finding assets that will grow taxfree over time to help you build on your financial future. April’s Legal Eagle column with David J. Goldberg, MD, JD, outlines who is liable for what in an electronic health record system glitch. He also shares insight on how you can best protect your practice and sensitive data.
We look forward to continually serving you with news to enhance dermatologic care, your practice, and patient outcomes. Be sure to stay connected with the Dermatology Times team between print issues by following us on social media, subscribing to e-newsletters, and emailing article ideas and insights to
Mike Hennessy Jr
President and CEO, MJH Life Sciences®
Articles in this issue
over 2 years ago
Discovering Dermatology Times: April 2023over 2 years ago
The Liability of an Electronic Health Record Systemover 2 years ago
Looking for Tax Advantages? Consider These 2 Asset Classesover 2 years ago
Soda Linked to Higher Risk of Male Baldnessover 2 years ago
Advances in Rosacea Therapyover 2 years ago
Lipid-Lowering PCSK9 Inhibitors May Reduce Psoriasis Riskover 2 years ago
The Amazing Skin Microbiomealmost 3 years ago
Biologics vs JAKs for Atopic Dermatitis: The Great DebateNewsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















